Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

BLCO

Bausch & Lomb Corp

Industrials · Ophthalmic Goods

$16.86Sep 25, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

Bausch & Lomb Corp shows stable business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue +9% YoY in Q2 FY2026.

TrajectoryStable

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

  • Revenue +9% YoY in Q2 FY2026

Pipeline evidence · 22d ago

BLCO's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on BLCO.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full BLCO earnings analysis

Reported figures for Bausch & Lomb Corp — research only, not investment advice.

Revenue YoY
+8.6%

Latest Intelligence

Updated

What happened recently for Bausch & Lomb Corp (BLCO) — events, not interpretation.

Event
Reported Q2 2026 revenue +9% YoY.
Also
Last session September 25, 2026 at $16.86.
Source
Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

Bausch & Lomb Corp (BLCO)

Industrials · Ophthalmic Goods

Investment Snapshot above is the primary AlphaOS analysis for Bausch & Lomb Corp — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Market cap:
$6.02B
Revenue:
$1.39B

BLCO earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Bausch & Lomb Corp through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.